The effectiveness of psychological interventions alone, or in combination with phosphodiesterase-5 inhibitors, for the treatment of erectile dysfunction:A systematic review

被引:6
|
作者
Atallah, Sandrine [1 ]
Haydar, Asad [2 ]
Jabbour, Teddy [2 ]
Kfoury, Peter [3 ]
Sader, Georgio [2 ]
机构
[1] Amer Univ Beirut Med Ctr AUBMC, Dept Obstet & Gynecol, Beirut, Lebanon
[2] Univ Balamand, Fac Med, Koura, Lebanon
[3] Amer Univ Beirut, Fac Med, Beirut, Lebanon
关键词
Erectile dysfunction; systematic review; psychological intervention; combined therapy; phosphodiesterase; 5; inhibitors; cognitive behavioural therapy; 4TH INTERNATIONAL CONSULTATION; COGNITIVE-BEHAVIORAL THERAPY; SEX THERAPY; CONSENSUS STATEMENT; ADJUNCT TREATMENT; YOUNG MEN; HEALTH; SILDENAFIL; MEDICINE; PSYCHOTHERAPY;
D O I
10.1080/2090598X.2021.1926763
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To highlight the efficacy of various psychological interventions (PI) when used in combination with, or in place of, phosphodiesterase-5 inhibitors (PDE-5i), as compared to the traditional treatment of men with erectile dysfunction (ED) with PDE-5i alone. Methods: A comprehensive literature review for the years 2005-2020 via MEDLINE and PubMed. We included randomised controlled trials that compared the use of either PDE-5i alone, PI alone or a combination of PDE-5i and PI in the treatment of psychogenic ED. All studies included were performed in adults aged 19-55 years and were written in English. Results: A total of 13 articles, with an overall sample of 597 men, were included in this systematic review. The results show that the combination of PI and PDE-5i was more effective than either PI or PDE-5i alone, on erectile function and long-term sexual satisfaction in men with psychogenic ED. Combined interventions were found to be significantly superior to medical treatment in seven studies and to PI alone in one study. In comparing PI to PDE-5i, two studies found PI to be significantly superior to PDE-51 use. In three other studies, PI was found significantly superior to no treatment at all, although some participants in the control group had taken PDE-5i. Conclusions: The combination of PDE-5i with PI shows real promise for the treatment of psychogenic ED. However, no conclusions could be made about what PI is more promising than the other and larger studies are needed to confirm these initial findings.
引用
收藏
页码:310 / 322
页数:13
相关论文
共 50 条
  • [31] Zotarolimus-Eluting Peripheral Stents for the Treatment of Erectile Dysfunction in Subjects With Suboptimal Response to Phosphodiesterase-5 Inhibitors
    Rogers, Jason H.
    Goldstein, Irwin
    Kandzari, David E.
    Koehler, Tobias S.
    Stinis, Curtiss T.
    Wagner, Paula J.
    Popma, Jeffrey J.
    Jaff, Michael R.
    Rocha-Singh, Krishna J.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (25) : 2618 - 2627
  • [32] Correction of endothelial dysfunction by inhibitors of phosphodiesterase-5 in combination with L-arginine
    Pokrovskaya, Tatiana
    Pokrovsky, Mikhail
    Dudina, Eleonora
    Konovalova, Elena
    Kochkarov, Vladimir
    Kolesnik, Inga
    Korokin, Mikhail
    Gudyrev, Oleg
    Arustamova, Anna
    Bontsevich, Roman
    Chetverikova, Anna
    Korobtsova, Irina
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [33] Aortic Stiffness and the Response to Phosphodiesterase-5 Inhibitors in Patients Receiving Treatment for Erectile Dysfunction: Predictive Role or an Epiphenomenon?
    Tibirica, Eduardo
    [J]. ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2024, 121 (03)
  • [34] Effect of different physical activities on erectile dysfunction in adult men not receiving phosphodiesterase-5 inhibitors therapy: A systematic review and meta-analysis
    Chen, Zihao
    Wang, Jiaxin
    Jia, Junqiang
    Wu, Chunhui
    Song, Jiulong
    Tu, Jiayuan
    [J]. ANDROLOGY, 2024,
  • [35] Phosphodiesterase-5 inhibition: the molecular biology of erectile function and dysfunction
    Francis, SH
    Corbin, JD
    [J]. UROLOGIC CLINICS OF NORTH AMERICA, 2005, 32 (04) : 419 - +
  • [36] Comparative Effectiveness and Safety of Oral Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction: A Systematic Review and Network Meta-analysis
    Yuan, JinQiu
    Zhang, RenJie
    Yang, ZuYao
    Lee, Jack
    Liu, YaLi
    Tian, JinHui
    Qin, XiWen
    Ren, ZhengJia
    Ding, Hong
    Chen, Qing
    Mao, Chen
    Tang, JinLing
    [J]. EUROPEAN UROLOGY, 2013, 63 (05) : 902 - 912
  • [37] Phosphodiesterase type 5 inhibitors for erectile dysfunction
    Carson, CC
    Lue, TF
    [J]. BJU INTERNATIONAL, 2005, 96 (03) : 257 - 280
  • [38] Phosphodiesterase type 5 inhibitors and erectile dysfunction
    Whittaker, C.
    [J]. SOUTH AFRICAN FAMILY PRACTICE, 2010, 52 (03) : 207 - 210
  • [39] Phosphodiesterase Type 5 Inhibitors and Erectile Dysfunction
    Whittaker, Catherine
    [J]. SA PHARMACEUTICAL JOURNAL, 2009, 76 (05) : 24 - 26
  • [40] Effect of Phosphodiesterase-5 Inhibitors on the Treatment of Male Infertility: A Systematic Review and Meta-Analysis
    Dong, Liang
    Zhang, Xiaojin
    Yan, Xuhong
    Shen, Yifeng
    Li, Yulin
    Yu, Xujun
    [J]. WORLD JOURNAL OF MENS HEALTH, 2021, 39 (04): : 776 - 796